🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 4 Study to evaluate the safety and effect on decreasing subjects' alb...
Status
Completed
Location
Korea University, Anam
Start Date
2013-02-01
Trial ID
NCT01869881
Treatments Being Tested
The purpose of this study is compare the safety and pharmacokinetic charact...
Status
Completed
Location
Samsung Medical Center
Start Date
2011-02
Trial ID
NCT01421563
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics of sarpogrela...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01841086
Treatments Being Tested
Background: Contrast-induced nephropathy (CIN) is a serious clinical probl...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2009-12
Trial ID
NCT01165567
Treatments Being Tested
This study is to evaluate the effect of sarpogrelate on blood viscosity aft...
Status
Completed
Location
The Catholic University of Korea, Uijeongbu ST. Mary's Hospital
Start Date
2018-10-11
Trial ID
NCT03509922
Treatments Being Tested
The purpose of this study is compare the safety and pharmacokinetic charact...
Status
Completed
Location
Samsung Medical Center
Start Date
2011-07
Trial ID
NCT01429688
Treatments Being Tested
Sarpogrelate (MCI-9042) is an antiplatelet drug that decreases 5-hydroxytry...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00129805
This clinical trial aims to assess the non-inferiority of Sarpogrelate SR 3...
Status
Completed
Location
GangNeung Asan Hospital
Start Date
2020-11-18
Trial ID
NCT06046196
Treatments Being Tested
This is a prospective interventional study to assess the effect of sarpogre...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2015-07
Trial ID
NCT02607436
Treatments Being Tested
Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, has been widely ...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT02393612
Treatments Being Tested